Cargando…
A pandemic will not stop metabolic innovation
Autores principales: | MacLeod, Erin, Starin, Danielle, Ah Mew, Nicholas, Regier, Debra S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243753/ https://www.ncbi.nlm.nih.gov/pubmed/32461011 http://dx.doi.org/10.1016/j.ymgme.2020.05.007 |
Ejemplares similares
-
Maple syrup urine disease decompensation misdiagnosed as a psychotic event
por: Higashimoto, Tomoyasu, et al.
Publicado: (2022) -
Virtual nutrition class curriculum development for patients with inborn errors of metabolism to curb COVID 19 isolation
por: MacLeod, EL, et al.
Publicado: (2022) -
Elevated urine oxalate and renal calculi in a classic galactosemia patient on soy‐based formula
por: Sabatino, Julia A., et al.
Publicado: (2019) -
Key Challenges in the Search for Innovative Drug Treatments for Special Populations. Converging Needs in Neonatology, Pediatrics, and Medical Genetics
por: MacLeod, Stuart
Publicado: (2017) -
SULFHYDRYL GROUPS IN RELATION TO THE METABOLISM AND MOTILITY OF HUMAN SPERMATOZOA
por: MacLeod, John
Publicado: (1951)